Cancer Information Highlights, August 14, 2019

Having trouble viewing this email? View it as a Web page.

Cancer Information Highlights From the National Cancer Institute Updating you about cancer causes, prevention, screening, treatment, coping, and more   New from NCI Are Different Criteria for Lung Cancer Screening Needed for African Americans?   Guidelines on who should be screened for lung cancer are based largely on how long a person smoked and the number of cigarettes they smoked. But a new study suggests that current guidelines may need to be reviewed when it comes to African Americans. Targeted Drug Is Effective for Some People with Advanced Bladder Cancer New clinical trial findings confirm that the targeted therapy erdafitinib (Balversa) can benefit patients with advanced bladder cancer whose tumors have a certain genetic change. Learn more about the trial. Advances in Leukemia Research NCI-funded researchers are working to advance our understanding of leukemia. Learn how recent advances in leukemia research may lead to more effective and less toxic treatments.   Also of Interest CAR T Cells: Engineering Immune Cells to Treat Cancer CAR T-cell therapy is a rapidly emerging form of cancer immunotherapy that uses a person's own immune cells to treat their cancer. Learn about research efforts to improve CAR T-cell therapy and expand its use. Human Papillomavirus (HPV) Vaccines During National Immunization Awareness Month, learn about the HPV vaccine, including who should get it, how it works, and why it is important.

Stay Connected with the National Cancer Institute
Chat with us: LiveHelp       Call us: 1-800-4-CANCER (1-800-422-6237) SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

 

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892